Follow
Frederik Peters
Frederik Peters
Hamburg Cancer Registry, Germany
Verified email at bwfgb.hamburg.de - Homepage
Title
Cited by
Cited by
Year
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations
J Temme, F Peters, K Lange, Y Pirson, L Heidet, R Torra, JP Grunfeld, ...
Kidney international 81 (8), 779-783, 2012
1522012
Editor's choice–long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis
CA Behrendt, A Sedrakyan, F Peters, T Kreutzburg, M Schermerhorn, ...
European Journal of Vascular and Endovascular Surgery 59 (4), 587-596, 2020
1172020
Editor's Choice–comorbidity patterns among patients with peripheral arterial occlusive disease in Germany: a trend analysis of health insurance claims data
T Kreutzburg, F Peters, HC Rieß, S Hischke, U Marschall, L Kriston, ...
European Journal of Vascular and Endovascular Surgery 59 (1), 59-66, 2020
1062020
Contribution of smoking to socioeconomic inequalities in mortality: a study of 14 European countries, 1990–2004
G Gregoraci, FJ Van Lenthe, B Artnik, M Bopp, P Deboosere, K Kovács, ...
Tobacco control 26 (3), 260-268, 2017
1032017
Outcomes of male patients with Alport syndrome undergoing renal replacement therapy
J Temme, A Kramer, KJ Jager, K Lange, F Peters, GA Müller, R Kramar, ...
Clinical Journal of the American Society of Nephrology 7 (12), 1969-1976, 2012
782012
Editor's choice–optimal pharmacological treatment of symptomatic peripheral arterial occlusive disease and evidence of female patient disadvantage: an analysis of health …
F Peters, T Kreutzburg, HC Rieß, F Heidemann, U Marschall, H L'Hoest, ...
European Journal of Vascular and Endovascular Surgery 60 (3), 421-429, 2020
562020
Editor's Choice–The GermanVasc score: a pragmatic risk score predicts five year amputation free survival in patients with peripheral arterial occlusive disease
T Kreutzburg, F Peters, J Kuchenbecker, U Marschall, R Lee, L Kriston, ...
European Journal of Vascular and Endovascular Surgery 61 (2), 248-256, 2021
502021
Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level
M Gheorghe, P Wubulihasimu, F Peters, W Nusselder, PHM Van Baal
The European Journal of Public Health 26 (5), 794-799, 2016
372016
Long‐Term Effectiveness and Safety of Initiating Statin Therapy After Index Revascularization In Patients With Peripheral Arterial Occlusive Disease
F Peters, J Kuchenbecker, T Kreutzburg, U Marschall, ES Debus, ...
Journal of the American Heart Association 9 (22), e018338, 2020
362020
Long term outcomes after revascularisations below the knee with paclitaxel coated devices: a propensity score matched cohort analysis
F Heidemann, F Peters, J Kuchenbecker, T Kreutzburg, A Sedrakyan, ...
European Journal of Vascular and Endovascular Surgery 60 (4), 549-558, 2020
362020
Order-specific fertility rates for Germany: Estimates from Perinatal Statistics for the period 2001-2008
M Kreyenfeld, R Scholz, F Peters, I Wlosnewski
Comparative Population Studies 35 (2), 2010
362010
Forecasting differences in life expectancy by education
P Van Baal, F Peters, J Mackenbach, W Nusselder
Population studies 70 (2), 201-216, 2016
342016
The OAC3-PAD risk score predicts major bleeding events one year after hospitalisation for peripheral artery disease
CA Behrendt, T Kreutzburg, J Nordanstig, CP Twine, U Marschall, ...
European Journal of Vascular and Endovascular Surgery 63 (3), 503-510, 2022
332022
The prospective GermanVasc cohort study
A Kotov, F Peters, ES Debus, T Zeller, P Heider, K Stavroulakis, J Remig, ...
Vasa, 2021
302021
Editor's Choice–Prevalence of Peripheral Arterial Disease, Abdominal Aortic Aneurysm, and Risk Factors in the Hamburg City Health Study: A Cross Sectional Analysis
CA Behrendt, G Thomalla, DL Rimmele, EL Petersen, R Twerenbold, ...
European Journal of Vascular and Endovascular Surgery 65 (4), 590-598, 2023
262023
The swinging pendulum of evidence: Is there a reality behind results from randomised trials and real world data? Lessons learned from the paclitaxel debate
CA Behrendt, F Peters, K Mani
European Journal of Vascular and Endovascular Surgery 59 (4), 510-511, 2020
222020
Long-term incidence of cancer after index treatment for symptomatic peripheral arterial disease–a health insurance claims data analysis
M Kaschwich, F Peters, S Hischke, HC Rieß, M Gansel, U Marschall, ...
Vasa, 2020
212020
Distribution of mobile health applications amongst patients with symptomatic peripheral arterial disease in Germany: a cross-sectional survey study
K Alushi, I Hinterseher, F Peters, U Rother, MS Bischoff, S Mylonas, ...
Journal of Clinical Medicine 11 (3), 498, 2022
202022
A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive …
F Heidemann, J Kuchenbecker, F Peters, A Kotov, U Marschall, H L'Hoest, ...
Journal of vascular surgery 74 (3), 780-787. e7, 2021
202021
Quality of care in surgical/interventional vascular medicine: what can routinely collected data from the insurance companies achieve?
F Peters, T Kreutzburg, J Kuchenbecker, U Marschall, M Remmel, ...
Gefässchirurgie 25, 530-540, 2020
20*2020
The system can't perform the operation now. Try again later.
Articles 1–20